A phase II non-randomized open labeled trial for preoperative circadian chronomodulated hepatic arterial infusion (HAI) chemotherapy combined with panitumumab for liver metastases from colorectal cancer.
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2624492
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Chronomodulated HAI chemotherapy group The patients of this group will receive 6 cycles of chronomodulated HAI chemotherapy with 5-FU/LV/L-OHP before hepatectomy for liver metastases from colorectal cancer
Chronomodulated HAI chemotherapy with Panitumumab group The patients of this group will receive 6 cycles of chronomodulated HAI chemotherapy with 5-FU/LV/L-OHP and Panitumumab before hepatectomy for liver metastases from colorectal cancer
Primary outcome(s): Response rate
Study Design: Parallel Non-randomized
创建时间：
2012-10-15
